BUY | SELL | ||
---|---|---|---|
QTY | PRICE | PRICE | QTY |
250 | 318.00 | 319.60 | 3 |
95 | 317.50 | 319.70 | 65 |
25 | 317.45 | 319.75 | 25 |
56 | 317.30 | 319.80 | 15 |
445 | 317.15 | 319.85 | 10 |
2910 | Total | Total | 983 |
BUY | SELL | ||
---|---|---|---|
QTY | PRICE | PRICE | QTY |
250 | 318.00 | 319.60 | 3 |
95 | 317.50 | 319.70 | 65 |
25 | 317.45 | 319.75 | 25 |
56 | 317.30 | 319.80 | 15 |
445 | 317.15 | 319.85 | 10 |
2910 | Total | Total | 983 |
Open | 320.89 |
Previous Close | 319.24 |
Volume | 108,947.00 |
Value (Lacs) | 345.78 |
VWAP | 313.76 |
Beta | |
Mkt Cap (Rs. Cr.) | 317 |
High | 324.81 |
Low | 303.65 |
UC Limit | 351.16 |
LC Limit | 287.31 |
52 Week High | 447.50 |
52 Week Low | 203.62 |
Face Value | 10.00 |
All Time High | 2,315.00 |
All Time Low | 203.62 |
20D Avg Volume | 58,650 |
20D Avg Delivery(%) | 46.60 |
Book Value Per Share | 194.30 |
Dividend Yield | 0.00 |
TTM EPS See historical trend | 4.11 (+690.91% YoY) |
TTM PE See historical trend | 77.22 (High PE) |
P/B See historical trend | 1.64 (Average P/B) |
Sector PE | 62.10 |
*Delayed by 20 seconds.
Stock Score
Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
---|---|---|---|---|---|---|---|
Classic | - - | - - | - - | - - | - - | - - | - - |
Fibonacci | - - | - - | - - | - - | - - | - - | - - |
Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
R1 | - - | Pivot - - |
S1 | - - |
R2 | - - | S2 | - - | |
R3 | - - | S3 | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
Days | |
---|---|
5 | - - |
10 | - - |
20 | - - |
50 | - - |
100 | - - |
200 | - - |
Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
---|---|---|---|---|---|---|---|
Classic | - - | - - | - - | - - | - - | - - | - - |
Fibonacci | - - | - - | - - | - - | - - | - - | - - |
Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
R1 | - - | Pivot - - |
S1 | - - |
R2 | - - | S2 | - - | |
R3 | - - | S3 | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
Days |
---|
Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
---|---|---|---|---|---|---|---|
Classic | - - | - - | - - | - - | - - | - - | - - |
Fibonacci | - - | - - | - - | - - | - - | - - | - - |
Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
R1 | - - | Pivot - - |
S1 | - - |
R2 | - - | S2 | - - | |
R3 | - - | S3 | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
Days |
---|
1 Week | --% | |
1 Month | --% | |
3 Months | --% | |
YTD | --% | |
1 Year | --% | |
3 Years | --% |
3 out of 5 years Nureca has given negative returns in October.
Month | Max. Positive Change(%) | Avg. Positive Change(%) | Max. Negative Change(%) | Avg. Negative Change(%) | Average Change(%) |
---|---|---|---|---|---|
October | 37.67% | 22.09% | -18.84% (2024) | -10.63% | 2.46% |
Nureca Standalone September 2025 Net Sales at Rs 37.84 crore, up 16.9% Y-o-Y Oct 17 2025 02:19 PM
Nureca Consolidated June 2025 Net Sales at Rs 34.18 crore, up 68.61% Y-o-Y Jul 16 2025 09:50 AM
Nureca Standalone June 2025 Net Sales at Rs 34.32 crore, up 47.24% Y-o-Y Jul 16 2025 09:14 AM
Nureca Consolidated March 2025 Net Sales at Rs 31.74 crore, up 87.04% Y-o-Y May 06 2025 11:41 AM
*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.
Qty 116711 | Price 401.94 | % Traded 1.15 |
Qty 63937 | Price 409.84 | % Traded 0.64 |
Qty 63937 | Price 409.49 | % Traded 0.64 |
Qty 65679 | Price 363.99 | % Traded 0.64 |
Qty 51679 | Price 360.28 | % Traded 0.50 |
Qty 158000 | Price 358.81 | % Traded 1.49 |
Qty 95867 | Price 362.41 | % Traded 0.91 |
Qty 95867 | Price 362.11 | % Traded 0.91 |
*A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.
Date | Agenda |
---|
Ex-Date | Type | Dividend (Rs) |
---|
Announcement Date | Ex-Bonus | Ratio |
---|
Ex-Split | Old FV | New FV |
---|
Ex-Right | Ratio | Premium |
---|
Date | Agenda |
---|
Company Name | Price | % Chg | MCap(Cr) | TTM PE | P/B | ROE(%) | 1 Yr Perform(%) | Net Profit(Rs.) | Net Sales(Rs.) | Debt to Equity |
---|---|---|---|---|---|---|---|---|---|---|
Nureca | 313.12 | -1.92 | 313.13 | 126.77 | 1.62 | -0.34 | 6.29 | 0 | 114 | 0.01 |
Poly Medicure | 1,900.00 | -1.79 | 19,258.30 | 53.85 | 7.43 | 12.24 | -22.47 | 333 | 1,669 | 0.06 |
Indegene | 548.70 | -1.08 | 13,173.15 | 67.91 | 7.43 | 9.60 | -16.00 | 181 | 1,093 | 0.00 |
AARTIPHARM | 848.80 | 0.22 | 7,694.14 | 28.88 | 4.14 | 13.68 | 43.75 | 272 | 2,115 | 0.20 |
Prevest | 504.25 | -100.00 | 605.25 | 31.56 | 6.31 | 17.23 | -7.48 | 18 | 63 | 0.00 |